news

Next Level Aviation Appoints Louis Kucia as Vice President of Procurement

DANIA BEACH, Fla., Feb. 4, 2026 /PRNewswire/ -- Next Level Aviation® (NLA), a leader in the global distribution of used…

4 months ago

NYSE Content Update: Disney Names New CEO After Ringing Bell on Main Street USA

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 4, 2026 /PRNewswire/ -- The New York…

4 months ago

Hexaware Reports CY25 Revenue of USD 1,537.4 Mn, Marking 7.6% YoY Growth Q4CY25 Revenue at USD 389 Mn, Up 4.5% YoY, EBITDA Expands by 65 bps YoY

MUMBAI, India, Feb. 4, 2026 /PRNewswire/ -- Hexaware Technologies (NSE: HEXT), a global provider of IT solutions and services, today…

4 months ago

Agility: Global Logistics Execs Predict Volatile 2026

Industry looks to AI, cost controls, supply chain re-engineering as tools to copeABU DHABI, UAE, Feb. 4, 2026 /PRNewswire/ --…

4 months ago

InSolare Energy and Versogen Partner to Advance AEM Electrolyser Technology in India

MUMBAI, India, Feb. 4, 2026 /PRNewswire/ -- InSolare Energy Limited (IEL), one of India's leading renewable energy and Net zero…

4 months ago

NCCN Commemorates World Cancer Day with New Commitment to Update Patient Resources

The National Comprehensive Cancer Network pledges to update robust information resources for cancer patients and caregivers on an annual basis…

4 months ago

SANY Marine and CEA Forge Strategic Telehandler and Material Handling Partnership in Australia

ZHUHAI, China, Feb. 4, 2026 /PRNewswire/ -- SANY Marine, the port machinery BU of SANY Group, announced at its Global Customer Summit…

4 months ago

Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer

DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation from FDAClinical entry validates condensate modulator…

4 months ago

Novo Nordisk files annual report with the SEC

Bagsværd, Denmark, 4 February 2026 – Novo Nordisk A/S has filed its Annual Report 2025 on Form 20-F for the…

4 months ago

Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04

February 04, 2026 09:35 ET  | Source: Adial Pharmaceuticals, Inc GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial…

4 months ago